Jinxiu Li

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “DNA demethylating agents suppress preclinical models of synovial sarcoma”.

DNA demethylating agents suppress preclinical models of synovial sarcoma

Journal of Clinical Investigation(2025)10.1172/jci190855

N/A

0.241DataRank · unranked

4 citations

Nezha S. Benabdallah, Kyllie Smith-Fry, Li Li, Sarah McCollum, Jinxiu Li +13 more

Signaling modality within gp130 receptor enhances tissue regeneration

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.05.475124

N/A

0DataRank · unranked

1 citations

Candace Flynn, Emma Lamoure, Ben Van Handel, Arijita Sarkar, Jinxiu Li +14 more

Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis

Science Translational Medicine(2023)10.1126/scitranslmed.abq2395

N/A

0DataRank · unranked

20 citations

Candace Flynn, Emma Lamoure, Arijita Sarkar, Benjamin Handel, Jinxiu Li +15 more

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.25.591023

N/A

0DataRank · unranked

0 citations

Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi +34 more

Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma

Nature Communications(2025)10.1038/s41467-025-64665-8

N/A

0DataRank · unranked

8 citations

Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi +42 more